🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
This was a prospective, single center, open label, randomized study evaluat...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT02614937
Treatments Being Tested
The addition of an anti-inflammatory agent could be a valid option for cont...
Status
Completed
Location
Spedali Civili di Brescia
Start Date
2012-12
Trial ID
NCT02060604
Treatments Being Tested
The purpose of this study is to assess the tolerability and efficacy of ran...
Status
Completed
Location
Texas Retina Associates
Start Date
2014-09-23
Trial ID
NCT02222610
Treatments Being Tested
The aim of this study is to test if PF582 (ranibizumab) is safe and similar...
Status
Completed
Location
Eye Institute
Start Date
2013-11
Trial ID
NCT02121353
This is a Phase III, multicenter, randomized, double-masked, dose-compariso...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00891735
Treatments Being Tested
The purpose of this study is to investigate the change in macular edema and...
Status
Completed
Location
Dept. of Ophthalmology, Medical University of Vienna
Start Date
2007-10
Trial ID
NCT00682539
Treatments Being Tested
This clinical trial is designed to compare ranibizumab in comparison with D...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01396057
Treatments Being Tested
The objective of this clinical trial is to compare and evaluate the safety ...
Status
Unknown
Location
Hallym University Kangnam Sacred Heart Hospital
Start Date
2018-01-08
Trial ID
NCT03759860
The purpose of the study is to determine the effectiveness of Ranibizumab 0...
Status
Completed
Location
Northern California Retina Vitreous Associates
Start Date
2013-10
Trial ID
NCT01972763
Treatments Being Tested